ALDH1L1 (Aldehyde Dehydrogenase 1 Family Member L1) is a folate-metabolizing enzyme that catalyzes the oxidation of 10-formyltetrahydrofolate to tetrahydrofolate in the mitochondrial folate pathway. Located on chromosome 3q21.3, ALDH1L1 encodes a 902-amino acid protein with multiple functional domains. The enzyme is highly expressed in the liver and brain, particularly in astrocytes where it serves as a specific marker for mature astrocytes. ALDH1L1 plays a critical role in one-carbon metabolism by generating tetrahydrofolate (THF), which is essential for DNA synthesis, methylation reactions, and cellular redox balance.
The ALDH1L1 gene encodes a mitochondrial enzyme that sits at a crucial intersection of folate metabolism and cellular homeostasis. The enzyme converts 10-formyltetrahydrofolate (10-formyl-THF) to tetrahydrofolate (THF), simultaneously producing NADPH through its aldehyde dehydrogenase activity. This dual function positions ALDH1L1 as a key regulator of one-carbon metabolism that impacts DNA synthesis, methylation capacity, and cellular redox state—all processes critical to neuronal health and implicated in neurodegenerative diseases.
| ALDH1L1 |
|---|
| Gene Symbol | ALDH1L1 |
| Full Name | Aldehyde Dehydrogenase 1 Family Member L1 |
| Chromosome | 3q21.3 |
| NCBI Gene ID | 108 |
| OMIM | 600182 |
| Ensembl ID | ENSG00000135917 |
| UniProt ID | O75459 |
| Protein Name | Aldehyde dehydrogenase 1 family member L1 |
| Protein Class | Enzyme (Aldehyde dehydrogenase, formyltransferase) |
| Cellular Localization | Mitochondria (matrix) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neural Tube Defects, Cancer, Cognitive Impairment |
¶ Protein Structure and Function
ALDH1L1 is a multi-domain protein with several distinct functional regions:
- N-terminal Formyltransferase Domain: Transfers the formyl group from 10-formyl-THF to the aldehyde substrate
- Aldehyde Dehydrogenase (ALDH) Domain: Catalyzes oxidation of the formyl group, producing NADPH
- Tetrahydrofolate Binding Site: Binds THF for regeneration and release
- Mitochondrial Targeting Sequence: N-terminal signal for mitochondrial import
ALDH1L1 performs a unique two-step catalytic reaction:
- Formyl Transfer: The formyltransferase domain transfers the formyl group from 10-formyl-THF to a thiol group on the enzyme, forming a formyl-enzyme intermediate
- Oxidation: The ALDH domain oxidizes this intermediate, transferring electrons to NAD+ to form NADPH
This reaction simultaneously:
- Generates tetrahydrofolate (THF) for one-carbon metabolism
- Produces NADPH for biosynthetic reactions and antioxidant defense
The ALDH1L1 gene produces multiple splice variants:
- Full-length ALDH1L1 (902 aa): The canonical mitochondrial enzyme
- ALDH1L1-S: A shorter isoform lacking the mitochondrial targeting sequence, localizing to the cytosol
- ALDH1L1-2: An alternative splice variant with distinct tissue distribution
ALDH1L1 occupies a central position in the folate cycle:
flowchart TD
A["Folate (from diet)"] --> B["DHF"]
B --> C["THF"]
C --> D["10-formyl-THF"]
D -->|"ALDH1L1"| E["THF regenerated"]
D --> F["Purine Synthesis"]
E --> G["dUMP to dTMP"]
G --> H["DNA Synthesis"]
E --> I["Methylation"]
I --> J["DNA/RNA/Protein Methylation"]
E --> K["NADPH Production"]
K --> L["Redox Balance"]
K --> M["Biosynthesis"]
The ALDH1L1 reaction is a significant source of NADPH in mitochondria:
- NADPH is essential for:
- Glutathione reductase (antioxidant defense)
- Ribonucleotide reductase (DNA synthesis)
- Fatty acid synthesis
- Cytochrome P450 reactions
This makes ALDH1L1 crucial for maintaining cellular redox balance, particularly important in neurons with high metabolic demands.
Through generating THF, ALDH1L1 indirectly supports methylation reactions:
- THF accepts methyl groups to form 5-methyl-THF
- 5-methyl-THF donates methyl groups to homocysteine, forming methionine
- Methionine is converted to S-adenosylmethionine (SAM)
- SAM is the universal methyl donor for DNA, RNA, proteins, and lipids
ALDH1L1 exhibits a distinctive expression pattern:
High Expression:
- Liver (hepatocytes)
- Brain (astrocytes)
- Kidney
- Testis
- Oviduct
Moderate Expression:
- Small intestine
- Colon
- Pancreas
- Skeletal muscle
In the central nervous system, ALDH1L1 is predominantly expressed in:
- Astrocytes: Specifically in mature, differentiated astrocytes
- Bergmann glia (cerebellum)
- Radial glia (developmental)
- Ependymal cells
ALDH1L1 is NOT expressed in:
This astrocyte-specific expression makes ALDH1L1 one of the most specific astrocyte markers available for research.
Within astrocytes, ALDH1L1 localizes to:
- Mitochondrial matrix
- Astrocytic processes
- Perivascular end-feet
- Synaptic surrounding processes
ALDH1L1 and one-carbon metabolism have several connections to Alzheimer's disease:
-
Folate and Amyloid Metabolism: Folate-dependent metabolism affects amyloid precursor protein (APP) processing and amyloid-beta production . Altered one-carbon metabolism may:
- Influence amyloidogenic processing
- Affect amyloid clearance
- Modulate neuroinflammation
-
DNA Methylation: Alzheimer's disease is associated with widespread DNA hypomethylation. Folate deficiency reduces SAM availability, impairing methylation capacity .
-
Homocysteine Metabolism: Impaired folate metabolism leads to elevated homocysteine, a risk factor for AD and cognitive decline .
-
Tau Pathology: Folate-dependent methylation may influence tau protein post-translational modifications and aggregation .
-
Neuroinflammation: Astrocyte ALDH1L1 supports anti-inflammatory responses through proper folate metabolism and NADPH production.
ALDH1L1 has several connections to Parkinson's disease:
-
Dopaminergic Neuron Vulnerability: The substantia nigra has high metabolic demands. ALDH1L1-dependent NADPH production may be particularly important for antioxidant defense in these neurons.
-
Mitochondrial Dysfunction: PD involves mitochondrial complex I deficiency. Folate metabolism supports mitochondrial function through:
- NADPH for mitochondrial antioxidants
- Nucleotide synthesis for mitochondrial DNA
- Methylation for mitochondrial proteins
-
Levodopa Metabolism: Folate status affects levodopa metabolism and efficacy.
-
Neuroinflammation: Astrocyte activation in PD may involve ALDH1L1 dysregulation.
-
Amyotrophic Lateral Sclerosis (ALS): Altered one-carbon metabolism has been reported in ALS patients.
-
Huntington's Disease: Folate metabolism may be affected in HD, with potential therapeutic implications.
-
Multiple Sclerosis: Demyelination involves altered folate metabolism in astrocytes.
-
Aging: One-carbon metabolism declines with age, potentially contributing to age-related cognitive decline.
ALDH1L1 in astrocytes supports neuronal function through:
- Folate Supply: Astrocytes release folate derivatives for neuronal use
- NADPH for Antioxidant Defense: Astrocytic NADPH supports both astrocyte and neuronal antioxidant defenses through the glutathione system
- Methylation Support: SAM produced in astrocytes supports neuronal methylation reactions
- Neurotransmitter Cycling: Proper astrocyte metabolism supports glutamate and GABA cycling
ALDH1L1-generated NADPH is critical for:
flowchart LR
subgraph NADPH Sources
A["ALDH1L1"] --> B["NADPH"]
C["Other sources"] --> B
end
subgraph NADPH Consumers
B --> D["Glutathione Reductase"]
B --> E["Ribonucleotide Reductase"]
B --> F["Cytochrome P450"]
end
D --> G["Glutathione Regeneration"]
E --> H["DNA Synthesis"]
F --> I["Detoxification"]
Through THF production, ALDH1L1 supports:
- DNA methylation (via SAM)
- Histone methylation
- RNA methylation
- Chromatin remodeling
These epigenetic modifications are crucial for:
- Gene expression regulation
- Neuronal differentiation
- Synaptic plasticity
- Memory formation
Understanding ALDH1L1 function has led to therapeutic approaches:
- Folic Acid Supplementation: Used in AD and PD clinical trials with mixed results
- 5-Methyltetrahydrofolate (5-MTHF): The active form may be more effective than folic acid
- L-methylfolate: A medical food for patients with MTHFR polymorphisms
Direct modulation of ALDH1L1 is challenging but potentially valuable:
- Activation: Could enhance NADPH production and support antioxidant defense
- Inhibition: May have utility in certain cancer contexts
- Blood-brain barrier penetration
- Individual genetic variation (MTHFR polymorphisms)
- Potential for compensatory mechanisms
- Optimal timing of intervention
ALDH1L1 intersects with several key cellular mechanisms:
ALDH1L1 is a folate-metabolizing enzyme and specific astrocyte marker that plays critical roles in one-carbon metabolism, NADPH production, and cellular redox balance. Its astrocyte-specific expression makes it invaluable for research on astrocyte involvement in neurodegeneration, while its enzymatic function connects folate metabolism to DNA synthesis, methylation, and antioxidant defense—all processes fundamental to neuronal health and implicated in AD, PD, and related conditions.
Astrocytes provide crucial metabolic support to neurons:
- Glucose Metabolism: Astrocytes metabolize glucose and share intermediates with neurons
- Folate Cycling: Astrocytes take up folate, metabolize it through ALDH1L1, and release derivatives for neurons
- Glycogen Storage: Astrocytes store glycogen for times of high neuronal demand
- Potassium Buffering: Astrocytes take up excess extracellular potassium
- Water Homeostasis: Astrocyte water channels help maintain extracellular balance
The mitochondrial folate pathway:
- Import: Folate is imported into mitochondria via specific transporters
- Activation: Mitochondrial enzymes convert folate to 10-formyl-THF
- ALDH1L1 Reaction: ALDH1L1 converts 10-formyl-THF to THF, producing NADPH
- Output: THF is exported to the cytosol for further metabolism
This mitochondrial folate cycle is distinct from the cytosolic one-carbon pool and has specific functions in:
- Mitochondrial DNA synthesis (dTMP)
- Mitochondrial NADPH production
- Mitochondrial protein methylation
- Iron-sulfur cluster biosynthesis
¶ Folate and Neurodevelopment
During neural development, folate is essential for:
- Neural Tube Closure: Folate prevents neural tube defects
- Proliferation: Rapid cell division requires folate for nucleotide synthesis
- Differentiation: Epigenetic regulation via methylation supports differentiation
- Migration: Folate-dependent processes affect neuronal migration
- Synaptogenesis: Proper synapse formation requires folate metabolism
Maternal folate status during pregnancy affects:
- Neural tube closure
- Brain development
- Long-term neurocognitive outcomes
When ALDH1L1 function or folate availability is compromised:
- Reduced DNA Synthesis: Impaired dTMP production affects DNA replication and repair
- Methylation Defects: Reduced SAM leads to DNA hypomethylation
- Oxidative Stress: NADPH deficiency compromises antioxidant defenses
- Homocysteine Accumulation: Elevated homocysteine is neurotoxic
- Impaired Mitochondrial Function: Reduced mitochondrial DNA synthesis
¶ Neuroinflammation and ALDH1L1
Astrocyte activation (reactive astrogliosis) involves changes in ALDH1L1:
- Upregulation in Some Contexts: Activated astrocytes may increase ALDH1L1
- Downregulation in Others: Chronic inflammation may suppress ALDH1L1
- Functional Consequences: Altered ALDH1L1 affects inflammatory responses
- Therapeutic Implications: Modulating ALDH1L1 may influence neuroinflammation
Mice lacking ALDH1L1 show:
- Accumulation of 10-formyl-THF
- Reduced THF and downstream metabolites
- Growth retardation
- Neural tube defects in some backgrounds
- Increased sensitivity to oxidative stress
- Behavioral abnormalities
- ALDH1L1 Variants: Some single nucleotide polymorphisms (SNPs) have been associated with:
- Neural tube defect risk
- Cognitive function
- Cancer risk
- Expression Quantitative Trait Loci (eQTLs): Genetic variants affecting ALDH1L1 expression may influence disease risk
The MTHFR gene (not ALDH1L1) is commonly studied:
- C677T polymorphism: Reduces MTHFR activity
- A1298C polymorphism: May affect enzyme function
- Both are associated with elevated homocysteine
- Interactions with ALDH1L1 function are complex
ALDH1L1 interacts with:
- Folate Metabolism Enzymes: MTHFD1, MTHFD2, MTHFR
- Mitochondrial Proteins: Import machinery, matrix enzymes
- Aldehyde Dehydrogenase Family: ALDH2, ALDH1L2
- Spectral Binding Partners: 14-3-3 proteins, chaperones
Key metabolites interacting with ALDH1L1:
- 10-formyltetrahydrofolate (substrate)
- Tetrahydrofolate (product)
- NAD+ (cofactor)
- NADPH (product)
- Formaldehyde (intermediate)
ALDH1L1 may be regulated by:
- Phosphorylation (potential)
- Acetylation
- Succination (in diabetes)
- Oxidative modifications
| Feature |
ALDH1L1 |
ALDH1L2 |
| Expression |
Astrocytes, liver |
Ubiquitous |
| Localization |
Mitochondria |
Mitochondria |
| Function |
Folate metabolism |
Similar but distinct |
| Disease Links |
Cancer, neurodegeneration |
Less studied |
- Conservation: Highly conserved across vertebrates
- Gene Duplications: ALDH1L1 and ALDH1L2 arose from gene duplication
- Species Differences: Some species show alternative splicing patterns
- Isoform-Specific Functions: How do different ALDH1L1 splice variants function?
- Astrocyte Subtype Differences: Does ALDH1L1 expression vary among astrocyte populations?
- Disease Mechanisms: What are the precise molecular links between ALDH1L1 dysfunction and neurodegeneration?
- Therapeutic Targeting: Can ALDH1L1 activity be modulated therapeutically?
- Single-Cell Analysis: Characterize ALDH1L1 expression in specific astrocyte subpopulations
- Spatial Transcriptomics: Map ALDH1L1 expression in brain regions
- Metabolomics: Define metabolic consequences of ALDH1L1 modulation
- Structural Studies: Determine ALDH1L1 structure for drug design
- iPSC Models: Generate patient-derived astrocytes to study disease mechanisms
ALDH1L1 has potential as a biomarker:
- Astrocyte Activation: Changes in ALDH1L1 may indicate astrogliosis
- Disease Progression: ALDH1L1 expression may correlate with disease stage
- Therapeutic Response: Changes in folate metabolism may predict treatment response
Folate and related interventions have been tested in:
- Alzheimer's Disease: Mixed results, with some studies showing benefit
- Parkinson's Disease: Folate supplementation trials ongoing
- Cognitive Decline: B vitamin supplementation shows some promise
- Vascular Dementia: Folate may be particularly beneficial
Understanding ALDH1L1 status may help:
- Identify Responders: Patients with folate metabolism defects may benefit most
- Guide Dosing: Individual variations in folate metabolism affect requirements
- Monitor Treatment: Biomarkers of one-carbon metabolism can track response